Poliwogg News

SBIO: An ETF to Play Biotech's Bounce Back From Disaster

After a rough start to the year, the biotech sector is surging again and beating the broader market. Here are three diversified, safe ways to play the trend.

With net assets of $140.54 million, this is the smallest and riskiest of our three biotech ETFs. The ALPS Medical Breakthroughs ETF seeks results that correspond to the performance of its underlying index, the Poliwogg Medical Breakthroughs Index, which is made up of small- and mid-cap stocks of biotech and pharmaceutical companies that have one or more drugs in either Phase II or Phase III FDA clinical trials...

Read More

Poliwogg In the News